$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000165495423001717 Filed on February 14, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$0.00	$0.00	$4.351M
YoY Change	-100.0%	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.243M	$1.905M	$1.217M
YoY Change	54.86%	56.55%	-53.17%
% of Gross Profit
Research & Development	$2.563M	$1.743M	$885.8K
YoY Change	105.29%	96.79%	-8.39%
% of Gross Profit
Depreciation & Amortization	$101.9K	$103.2K	$41.67K
YoY Change	33.42%	147.55%	-35.53%
% of Gross Profit
Operating Expenses	$4.806M	$3.648M	$3.118M
YoY Change	68.55%	16.99%
Operating Profit	-$4.806M	-$3.648M	-$869.7K
YoY Change	69.07%	319.49%	-75.61%
Interest Expense	$124.1K	$227.2K	$4.487M
YoY Change	-96.24%	-94.94%	158.8%
% of Operating Profit
Other Income/Expense, Net	-$124.1K	-$174.7K	-$4.487M
YoY Change	-103.76%	-96.11%	158.8%
Pretax Income	-$4.930M	-$3.823M	-$5.357M
YoY Change	-19.71%	-28.63%	1.08%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.930M	-$3.823M	-$5.357M
YoY Change	-19.71%	-28.63%	1.08%
Net Earnings / Revenue			-123.1%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.10	-$0.08	-$151.0K
COMMON SHARES
Basic Shares Outstanding	48.21M shares	48.16M shares	35.97M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.226M	$9.680M	$10.73M
YoY Change	-44.35%	-9.81%	266.69%
Cash & Equivalents	$6.226M	$9.680M	$10.73M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables			$3.125M
Other Receivables			$0.00
Total Short-Term Assets	$6.226M	$9.680M	$13.86M
YoY Change	-44.93%	-30.15%	373.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$699.7K	$770.7K	$672.3K
YoY Change	-32.55%	14.63%	214.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.77K	$15.77K	$13.77K
YoY Change	14.52%	14.52%	-45.31%
Total Long-Term Assets	$913.8K	$1.030M	$1.027M
YoY Change	-32.64%	0.33%	246.05%
TOTAL ASSETS
Total Short-Term Assets	$6.226M	$9.680M	$13.86M
Total Long-Term Assets	$913.8K	$1.030M	$1.027M
Total Assets	$7.140M	$10.71M	$14.88M
YoY Change	-43.62%	-28.05%	361.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$516.2K	$404.6K	$408.5K
YoY Change	25.33%	-0.95%	-29.66%
Accrued Expenses	$434.3K	$464.8K	$1.508M
YoY Change	63.37%	-69.18%	27.98%
Deferred Revenue
YoY Change
Short-Term Debt	$2.255M	$2.255M	$13.38M
YoY Change	0.0%	-83.14%	153.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.734M	$3.658M	$17.42M
YoY Change	-30.37%	-79.0%	121.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$431.8K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$4.140K	$45.99K	$171.6K
YoY Change	-97.01%	-73.2%	1075.21%
Total Long-Term Liabilities	$4.144K	$45.99K	$603.4K
YoY Change	-99.27%	-92.38%	4032.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.734M	$3.658M	$17.42M
Total Long-Term Liabilities	$4.144K	$45.99K	$603.4K
Total Liabilities	$3.739M	$3.704M	$18.03M
YoY Change	-36.99%	-79.45%	128.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$110.2M	-$105.2M	-$86.68M
YoY Change	18.67%	21.39%
Common Stock	$48.21K	$48.21K	$35.97K
YoY Change	10.22%	34.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.401M	$7.006M	-$3.141M
YoY Change
Total Liabilities & Shareholders Equity	$7.140M	$10.71M	$14.88M
YoY Change	-43.62%	-28.05%	361.71%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$4.930M	-$3.823M	-$5.357M
YoY Change	-19.71%	-28.63%	1.08%
Depreciation, Depletion And Amortization	$101.9K	$103.2K	$41.67K
YoY Change	33.42%	147.55%	-35.53%
Cash From Operating Activities	-$3.423M	-$2.917M	-$1.908M
YoY Change	-486.46%	52.92%	34.26%
INVESTING ACTIVITIES
Capital Expenditures	$31.01K	$10.85K	-$385.5K
YoY Change	-107.02%	-102.81%	3903.01%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$31.01K	-$10.85K	-$385.5K
YoY Change	-92.98%	-97.19%	3901.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.344K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$14.84K	$768.8K
YoY Change	-100.0%	-98.07%	1188.08%
NET CHANGE
Cash From Operating Activities	-3.423M	-$2.917M	-$1.908M
Cash From Investing Activities	-31.01K	-$10.85K	-$385.5K
Cash From Financing Activities	0.000	$14.84K	$768.8K
Net Change In Cash	-3.454M	-$2.913M	-$1.524M
YoY Change	-861.97%	91.11%	11.2%
FREE CASH FLOW
Cash From Operating Activities	-$3.423M	-$2.917M	-$1.908M
Capital Expenditures	$31.01K	$10.85K	-$385.5K
Free Cash Flow	-$3.454M	-$2.928M	-$1.522M
YoY Change	-360.25%	92.35%	7.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2255066	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	210790	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215397	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3658002	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3808635	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45993	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87118	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	45993	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48207937	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	112175814	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111209388	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105220597	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101397738	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7006231	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10710226	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13758366	usd
CY2022Q4	us-gaap	Revenues Revenues	0	usd
CY2022Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001074828
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Revenues Revenues	4351400	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1743051	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48207937	shares
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156062	shares
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	885752	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1905071	usd
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers	22564255	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	122018	shares
CY2022Q4	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe	21736313	shares
CY2021Q3	knwn	Outstanding At Begenning Of Period OutstandingAtBegenningOfPeriod	0.998
CY2022Q3	knwn	Outstanding At End Of Period OutstandingAtEndOfPeriod	1.029
CY2022Q4	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	50000	shares
CY2022Q1	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2027-01-05
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Entity File Number EntityFileNumber	000-30262
CY2022Q4	dei	Entity Registrant Name EntityRegistrantName	KNOW LABS, INC.
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0273142
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Union Street
CY2022Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 810
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
CY2022Q4	dei	City Area Code CityAreaCode	206
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	903-1351
CY2022Q4	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022Q4	dei	Trading Symbol TradingSymbol	KNW
CY2022Q4	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48207937	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9680272	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12593692	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9680272	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	12593692	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	770663	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	862977	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	15765	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	13767	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	243526	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	287930	usd
CY2022Q4	us-gaap	Assets Assets	10710226	usd
CY2022Q3	us-gaap	Assets Assets	13758366	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	404619	usd
CY2022Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	526968	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	464830	usd
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1216947	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462940	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	322697	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2255066	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	348264	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	87118	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156062	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	48209	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-869659	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	0	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	48158	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	227170	usd
CY2021Q4	us-gaap	Selling Expense SellingExpense	3118360	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	3648122	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	5221059	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3648122	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	4486960	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10733743	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14843	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q4	us-gaap	Other Income OtherIncome	52433	usd
CY2021Q4	us-gaap	Other Income OtherIncome	0	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-174737	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4486960	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3822859	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5356619	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3822859	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5356619	usd
CY2022Q4	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.08
CY2021Q4	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.15
CY2022Q4	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	48187339	shares
CY2021Q4	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	35479073	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2021Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	204170	usd
CY2021Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	766486	usd
CY2021Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2344	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5356619	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3141456	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2022Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	744640	usd
CY2022Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2343	usd
CY2022Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	12500	usd
CY2022Q4	knwn	Interest Expense For Extension Of Notes And Warrants InterestExpenseForExtensionOfNotesAndWarrants	206994	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3822859	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7006231	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3822859	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5356619	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103160	usd
CY2021Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41672	usd
CY2022Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	744640	usd
CY2021Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	204170	usd
CY2022Q4	knwn	Right Of Use Net RightOfUseNet	-1328	usd
CY2021Q4	knwn	Right Of Use Net RightOfUseNet	-1781	usd
CY2022Q4	us-gaap	Interest Expense Foreign Deposits InterestExpenseForeignDeposits	206994	usd
CY2021Q4	us-gaap	Interest Expense Foreign Deposits InterestExpenseForeignDeposits	0	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4184657	usd
CY2022Q4	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1998	usd
CY2021Q4	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-3124581	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-146026	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2917417	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1907817	usd
CY2022Q4	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	10846	usd
CY2021Q4	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	385488	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10846	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-385488	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2343	usd
CY2021Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2344	usd
CY2022Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12500	usd
CY2021Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	766486	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	768830	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2913420	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1524475	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12593692	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12258218	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9680272	usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2022Q4	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Revenue Recognition</em></strong><strong> </strong>– The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. During the three months ended December 31, 2021, the Company’s artificial AI deep learning platform generated revenue from digital asset sales of NFTs. The Company engineering team, using its research data, AI and proprietary algorithms, produced NFTs in the form of digital art. The NFTs produced had no recorded cost basis. The Company does not expect future activity or revenue from that source.</p>
CY2022Q4	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong><strong> – </strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of December 31, 2022 and September 30, 2022.</p>
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18423245	shares
CY2021Q4	knwn	Additional Common Shares Reserved AdditionalCommonSharesReserved	16124764	shares
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16464066	shares
CY2022Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4	knwn	Artificial Intelligence Ai Deep Learning Platform ArtificialIntelligenceAiDeepLearningPlatform	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. Artificial Intelligence (AI) Deep Learning Platform</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>AI Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended September 30, 2022, the Company’s AI deep learning platform began generating revenue from digital asset sales of NFTs and had sales of $4,360,087. The Company’s sales of NFTs are generated using the NFT digital exchange, OpenSea. Customers purchasing the NFT’s must make payments in the crypto currency, Ethereum. The Ethereum is received into a digital wallet and then moved to an account at Coinbase where the Ethereum is converted to U.S. dollars. During the three months ended December 31, 2021, the Company was not able to establish a digital wallet and corporate account at Coinbase in order to receive the Ethereum. The Company used the digital wallet and Coinbase account of the Company’s CEO. The Company and the CEO executed an assignment of his account to the Company while the Company establishes its own Coinbase account. All proceeds received from the sale of NFT were deposited in the CEO’s personal digital accounts. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After the sale of the NFT, the Ethereum was converted to US dollars as soon as practically possible. The Company recorded the total value of the gross NFT sale in revenue. Costs incurred in connection with the NFT transaction were recorded in the statement of operations as selling and transactional cost of digital assets and include costs to outside consultants, estimated employee and CEO special bonus compensation, digital asset conversion losses and estimated sales and use tax. The amount totaled $3,430,438 for the year ended September 30, 2022. As of December 31, 2022 and September 30, 2022, accrued expenses include $343,878 of expenses, primarily sales and use tax and other expenses.</p>
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	knwn	Convertible Notes Payable4 D ConvertibleNotesPayable4D	50000	usd
CY2022Q4	us-gaap	Interest Expense Other InterestExpenseOther	194019	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.565
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.618
CY2022Q4	knwn	Unrecognized Compensation Costs UnrecognizedCompensationCosts	11532729	usd
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	usd
CY2017Q2	knwn	Lease Description LeaseDescription	The monthly payment increases approximately 3% each year and the lease expired on May 31, 2022.
CY2021Q4	knwn	Extended Lease Amount ExtendedLeaseAmount	2986	usd
CY2021Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	usd
CY2021Q2	knwn	Lease Description LeaseDescription	increases by 3% annually. The lease expires on June 30, 2024. The lease can be extended for one additional three year term.
CY2021Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	5000	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	7000	usd
CY2022Q3	knwn	Lease Description LeaseDescription	The lease expires September 30, 2023 and can be extended on a month to month basis
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	91500	usd
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	21000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2250	usd
CY2022Q4	knwn	Segment Revenues SegmentRevenues	0	usd
CY2022Q4	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-3648000	usd
CY2022Q4	knwn	Segment Assets SegmentAssets	10710000	usd
CY2021Q4	knwn	Segment Revenues SegmentRevenues	4351000	usd
CY2021Q4	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-869000	usd
CY2021Q4	knwn	Segment Assets SegmentAssets	14885000	usd
CY2022Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	846472	usd
CY2021Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	244061	usd

Files In Submission

Name	View Source	Status
knwn-20221231_lab.xml	Edgar Link	unprocessable
0001654954-23-001717-index-headers.html	Edgar Link	pending
0001654954-23-001717-index.html	Edgar Link	pending
0001654954-23-001717.txt	Edgar Link	pending
0001654954-23-001717-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
know_10q.htm	Edgar Link	pending
know_10qimg1.jpg	Edgar Link	pending
know_ex108.htm	Edgar Link	pending
know_ex311.htm	Edgar Link	pending
know_ex312.htm	Edgar Link	pending
know_ex321.htm	Edgar Link	pending
know_ex322.htm	Edgar Link	pending
knwn-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
knwn-20221231_cal.xml	Edgar Link	unprocessable
know_10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
knwn-20221231_pre.xml	Edgar Link	unprocessable
knwn-20221231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2023 Q1 Form 10-Q Financial Statement

#000165495423001717 Filed on February 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2023 Q1 Form 10-Q Financial Statement

#000165495423001717 Filed on February 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw